ArticleAvicenna journal of medicine2022

Efficacy and Safety of SGLT2 Inhibitors as Adjunctive Treatment in Type 1 Diabetes in a Tertiary Care Center in Saudi Arabia.

Walla Fallatah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.